MX2009012096A - Axomadol para tratamiento de dolor con artritis. - Google Patents

Axomadol para tratamiento de dolor con artritis.

Info

Publication number
MX2009012096A
MX2009012096A MX2009012096A MX2009012096A MX2009012096A MX 2009012096 A MX2009012096 A MX 2009012096A MX 2009012096 A MX2009012096 A MX 2009012096A MX 2009012096 A MX2009012096 A MX 2009012096A MX 2009012096 A MX2009012096 A MX 2009012096A
Authority
MX
Mexico
Prior art keywords
axomadol
arthritis
treating pain
pain
treating
Prior art date
Application number
MX2009012096A
Other languages
English (en)
Inventor
Klaus Schiene
Petra Bloms-Funke
John Bothmer
Claudia Lefeber
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of MX2009012096A publication Critical patent/MX2009012096A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invención se relaciona con el uso de axomadol para la producción de un medicamento para el tratamiento de dolor con artritis.
MX2009012096A 2007-05-11 2008-05-09 Axomadol para tratamiento de dolor con artritis. MX2009012096A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007022790A DE102007022790A1 (de) 2007-05-11 2007-05-11 Axomadol zur Schmerzbehandlung bei Arthrose
PCT/EP2008/003755 WO2008138558A1 (de) 2007-05-11 2008-05-09 Axomadol zur schmerzbehandlung bei arthrose

Publications (1)

Publication Number Publication Date
MX2009012096A true MX2009012096A (es) 2009-11-23

Family

ID=39672675

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012096A MX2009012096A (es) 2007-05-11 2008-05-09 Axomadol para tratamiento de dolor con artritis.

Country Status (22)

Country Link
US (2) US20080306161A1 (es)
EP (1) EP2155179B1 (es)
JP (1) JP2010526786A (es)
KR (1) KR20100017781A (es)
CN (1) CN101742993A (es)
AT (1) ATE489947T1 (es)
AU (1) AU2008250621A1 (es)
CA (1) CA2685379A1 (es)
CY (1) CY1111328T1 (es)
DE (2) DE102007022790A1 (es)
DK (1) DK2155179T3 (es)
ES (1) ES2357355T3 (es)
HK (1) HK1141436A1 (es)
HR (1) HRP20110127T1 (es)
IL (1) IL202001A0 (es)
MX (1) MX2009012096A (es)
PL (1) PL2155179T3 (es)
PT (1) PT2155179E (es)
RU (1) RU2009145804A (es)
SI (1) SI2155179T1 (es)
WO (1) WO2008138558A1 (es)
ZA (1) ZA200907646B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011008298A2 (en) * 2009-07-16 2011-01-20 Nectid, Inc. Novel axomadol dosage forms
US20110053914A1 (en) 2009-08-28 2011-03-03 Gruenenthal Gmbh Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-Dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an Antiepileptic
EP2477960A1 (en) 2009-09-14 2012-07-25 Grünenthal GmbH Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol
US20120022294A1 (en) * 2010-06-30 2012-01-26 Gruenenthal Gmbh Axomadol or a Metabolite Thereof for Use in the Treatment of Irritable Bowel Syndrome

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE10004926A1 (de) * 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
DE10059413A1 (de) 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10109763A1 (de) 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
US20050176790A1 (en) * 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
AU2003283410A1 (en) * 2002-11-22 2004-06-18 Grunenthal Gmbh Combination of selected analgesics and cox-ii inhibitors
DE10333835A1 (de) * 2003-07-24 2005-03-10 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung
CA2572491A1 (en) * 2004-07-01 2006-01-12 Gruenenthal Gmbh Oral dosage form safeguarded against abuse
WO2006089708A1 (en) * 2005-02-25 2006-08-31 Grünenthal GmbH Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride
DE102005009217A1 (de) * 2005-02-25 2006-08-31 Grünenthal GmbH Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen

Also Published As

Publication number Publication date
ES2357355T3 (es) 2011-04-25
CN101742993A (zh) 2010-06-16
US20080306161A1 (en) 2008-12-11
EP2155179A1 (de) 2010-02-24
IL202001A0 (en) 2010-06-16
DK2155179T3 (da) 2011-03-07
EP2155179B1 (de) 2010-12-01
RU2009145804A (ru) 2011-06-20
WO2008138558A1 (de) 2008-11-20
HRP20110127T1 (hr) 2011-03-31
JP2010526786A (ja) 2010-08-05
DE502008001951D1 (de) 2011-01-13
CY1111328T1 (el) 2015-08-05
ZA200907646B (en) 2010-07-28
DE102007022790A1 (de) 2008-11-20
CA2685379A1 (en) 2008-11-20
SI2155179T1 (sl) 2011-03-31
ATE489947T1 (de) 2010-12-15
US20100331424A1 (en) 2010-12-30
PL2155179T3 (pl) 2011-05-31
PT2155179E (pt) 2011-03-07
KR20100017781A (ko) 2010-02-16
HK1141436A1 (en) 2010-11-12
AU2008250621A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
MX2009011346A (es) Tapentadol para tratamiento de dolor con artritis.
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2011008262A (es) Espiroamidas sustituidas como moduladores de b1r:.
ZA201003110B (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
TN2011000291A1 (en) Purine compounds
SG132645A1 (en) Process for the production of polyols based on natural oils
JO2931B1 (en) Double-substituted phthalazin compounds as antagonists of the cell-specific factor pathway
MX2009009415A (es) Compuestos de tetrahidroisoquinolina como moduladores del receptor h3 de la histamina.
NZ601350A (en) Method of treating arthritis
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
TN2012000610A1 (en) Heterocyclic compounds, their preparation and their therapeutic application
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
UA102515C2 (ru) Новая лекарственная форма
MX2009011999A (es) Extruidos con enmascaramiento del sabor mejorado.
MX2009013069A (es) Tratamiento de leucemia resistente al imatinib.
PH12017500270A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
UA103468C2 (ru) Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н3
MX2009012096A (es) Axomadol para tratamiento de dolor con artritis.
MX2010002032A (es) Uso de flibanserina para el tratamiento de sintomas vasomotores.
MX2009009361A (es) Nueva forma de dosificacion.
MX2009013921A (es) Material refractario sin forma, un proceso para producir un material refractario sin forma, humedo como la tierra, y al uso del material refractario sin forma.
UA96574C2 (ru) Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции
MX2009007054A (es) Uso terapeutico novedoso para tratar leucemia.
MY153768A (en) Use of anti-bacterial compounds having an anaesthetic effect

Legal Events

Date Code Title Description
FG Grant or registration